Delivery Order SPE2DB20D1004-SPE2DB25FNGUA
- Not listed
- The Defense Logistics Agency awarded a $2,796.14 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies vaccines, medications, medical devices, and...
- The Defense Logistics Agency awarded a delivery order valued at $1,724.75 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed price delivery order was executed on August 19, 2025, with an ultimate completion date of August 20, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.80 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on March 5, 2025, with completion expected by March 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open procurement procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing...
- The Defense Logistics Agency awarded a delivery order valued at $2,069.70 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on July 21, 2025, and the product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $68,990 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 21, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical delivery to be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a $13,798.00 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,237.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 21, 2025. This non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery is designated for performance at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,759.60 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is not subject to any set-aside designation and is scheduled for completion by September 10, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major...
- The Defense Logistics Agency Medical Supply Chain awarded a $15,540.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the contractor's corporate office...
- The Defense Logistics Agency awarded a $4,584.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a routine pharmaceutical procurement for military medical supply needs. This non-competitive delivery order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNGUADelivery Order
The Defense Logistics Agency awarded a $2,859.80 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of May 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle provides global pharmaceutical support, enabling the company to supply specialty medications, brand-name and generic drugs, vaccines, and medical commodities across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 5/2/25 |